Clinical Trial: Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational [Patient Registry]
Official Title: Immunologic and Genetic Profiles in Subsets of Morphea Patients
Brief Summary:
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically:
- How morphea behaves over time
- How frequently specific problems occur along with morphea (for example, arthritis)
- Whether morphea has an autoimmune background
Detailed Summary:
Sponsor: University of Texas Southwestern Medical Center
Current Primary Outcome: Activity/damage measurement in morphea as scored on the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) [ Time Frame: 5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Quality of life scores measured by the Dermatology Life Quality Index (DLQI) [ Time Frame: 5 years ]
Original Secondary Outcome: Same as current
Information By: University of Texas Southwestern Medical Center
Dates:
Date Received: February 25, 2013
Date Started: May 2007
Date Completion:
Last Updated: December 2, 2014
Last Verified: December 2014
